Pharma: Regeneron has reached a drug pricing agreement with the Trump administration to provide a new hearing-loss therapy at no cost.

Apr 23, 2026 - 15:50
 0  0
Pharma: Regeneron has reached a drug pricing agreement with the Trump administration to provide a new hearing-loss therapy at no cost.
Regeneron joins the ranks of major pharmaceutical companies making pricing concessions for both new and existing medications as part of agreements with the Trump administration. It's a significant shift in the industry! 💊💰 #Pharma #Healthcare

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0